BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24276546)

  • 1. PEGylated G-CSF (BBT-015), GM-CSF (BBT-007), and IL-11 (BBT-059) analogs enhance survival and hematopoietic cell recovery in a mouse model of the hematopoietic syndrome of the acute radiation syndrome.
    Plett PA; Chua HL; Sampson CH; Katz BP; Fam CM; Anderson LJ; Cox GN; Orschell CM
    Health Phys; 2014 Jan; 106(1):7-20. PubMed ID: 24276546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival efficacy of the PEGylated G-CSFs Maxy-G34 and neulasta in a mouse model of lethal H-ARS, and residual bone marrow damage in treated survivors.
    Chua HL; Plett PA; Sampson CH; Katz BP; Carnathan GW; MacVittie TJ; Lenden K; Orschell CM
    Health Phys; 2014 Jan; 106(1):21-38. PubMed ID: 24276547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): a review.
    Singh VK; Newman VL; Seed TM
    Cytokine; 2015 Jan; 71(1):22-37. PubMed ID: 25215458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multilineage hematopoietic recovery by a single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice.
    Shibuya K; Akahori H; Takahashi K; Tahara E; Kato T; Miyazaki H
    Blood; 1998 Jan; 91(1):37-45. PubMed ID: 9414267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated IL-11 (BBT-059): A Novel Radiation Countermeasure for Hematopoietic Acute Radiation Syndrome.
    Kumar VP; Biswas S; Sharma NK; Stone S; Fam CM; Cox GN; Ghosh SP
    Health Phys; 2018 Jul; 115(1):65-76. PubMed ID: 29787432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEG-G-CSF and L-Citrulline Combination Therapy for Mitigating Skin Wound Combined Radiation Injury in a Mouse Model.
    Wang L; Zhai M; Lin B; Cui W; Hull L; Li X; Anderson MN; Smith JT; Umali MV; Jiang S; Kiang JG; Xiao M
    Radiat Res; 2021 Jul; 196(1):113-127. PubMed ID: 33914884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo administration of granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage CSF, interleukin-1 (IL-1), and IL-4, alone and in combination, after allogeneic murine hematopoietic stem cell transplantation.
    Atkinson K; Matias C; Guiffre A; Seymour R; Cooley M; Biggs J; Munro V; Gillis S
    Blood; 1991 Mar; 77(6):1376-82. PubMed ID: 1705839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Therapy of Pegylated G-CSF and Alxn4100TPO Improves Survival and Mitigates Acute Radiation Syndrome after Whole-Body Ionizing Irradiation Alone and Followed by Wound Trauma.
    Kiang JG; Zhai M; Bolduc DL; Smith JT; Anderson MN; Ho C; Lin B; Jiang S
    Radiat Res; 2017 Nov; 188(5):476-490. PubMed ID: 28850300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a Long-Acting Site-Specific PEGylated Murine GM-CSF Analog and Analysis of Its Hematopoietic Properties in Normal and Cyclophosphamide-Treated Neutropenic Rats.
    Cox GN; Lee JI; Rosendahl MS; Chlipala EA; Doherty DH
    Protein J; 2020 Apr; 39(2):160-173. PubMed ID: 32172395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
    Peters WP; Rosner G; Ross M; Vredenburgh J; Meisenberg B; Gilbert C; Kurtzberg J
    Blood; 1993 Apr; 81(7):1709-19. PubMed ID: 7681699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys.
    Neelis KJ; Hartong SC; Egeland T; Thomas GR; Eaton DL; Wagemaker G
    Blood; 1997 Oct; 90(7):2565-73. PubMed ID: 9326222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cell growth factor (C-kit ligand) in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3: in vivo hemopoietic effects in irradiated mice compared to in vitro effects.
    Patchen ML; Fischer R; MacVittie TJ; Seiler FR; Williams DE
    Biotherapy; 1993; 7(1):13-26. PubMed ID: 7520725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
    Atkinson K; Vos B; Kang-Er Z; Guiffre A; Seymour R; Gillis S
    Cytokines Mol Ther; 1995 Mar; 1(1):47-55. PubMed ID: 9384663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of combined administration of interleukin-6 and granulocyte colony-stimulating factor on recovery from radiation-induced hemopoietic aplasia.
    Patchen ML; Fischer R; MacVittie TJ
    Exp Hematol; 1993 Feb; 21(2):338-44. PubMed ID: 7678816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gottingen minipig is a model of the hematopoietic acute radiation syndrome: G-colony stimulating factor stimulates hematopoiesis and enhances survival from lethal total-body γ-irradiation.
    Moroni M; Ngudiankama BF; Christensen C; Olsen CH; Owens R; Lombardini ED; Holt RK; Whitnall MH
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):986-92. PubMed ID: 23845847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
    Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
    Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Neulasta or Neupogen on H-ARS and GI-ARS Mortality and Hematopoietic Recovery in Nonhuman Primates After 10-Gy Irradiation With 2.5% Bone Marrow Sparing.
    Farese AM; Bennett AW; Gibbs AM; Hankey KG; Prado K; Jackson W; MacVittie TJ
    Health Phys; 2019 Mar; 116(3):339-353. PubMed ID: 30281533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance.
    Morris ES; MacDonald KP; Rowe V; Johnson DH; Banovic T; Clouston AD; Hill GR
    Blood; 2004 May; 103(9):3573-81. PubMed ID: 14726406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of use of G-CSF and GM-CSF in the treatment of acute radiation injury.
    Reeves G
    Health Phys; 2014 Jun; 106(6):699-703. PubMed ID: 24776902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megakaryocyte growth and development factor stimulates enhanced platelet recovery in mice after bone marrow transplantation.
    Molineux G; Hartley CA; McElroy P; McCrea C; McNiece IK
    Blood; 1996 Aug; 88(4):1509-14. PubMed ID: 8695873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.